The Motley Fool
30 Jun 2026, 08:02 UTC · 3h ago
5 Reasons Eli Lilly Is a Better Stock to Buy Right Now Than SpaceX
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
The Motley Fool
30 Jun 2026, 08:02 UTC · 3h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
What the story claims
4 claims · each scored for market impact
SpaceX completed a trillion-dollar IPO with an initial price of $135, though the stock has recently retreated toward the $150 mark. — The public listing of a massive private entity creates significant new liquidity and benchmark valuation for the space/tech sectors.
+0.60Eli Lilly holds over 60% of the U.S. GLP-1 weight loss drug market, with Mounjaro and Zepbound generating over $12 billion in the latest quarter. — Dominant market share and massive quarterly revenue growth in a high-demand sector drive strong bullish sentiment for LLY.
+0.50SpaceX reported a $4.9 billion loss last year, with AI capital expenditures alone exceeding $12 billion. — High cash burn and significant losses increase the risk profile for shareholders despite high growth potential.
-0.40Continue reading
6 related stories
Search tags
Eli Lilly has launched an oral weight loss drug, Foundayo, and has additional candidates in late-stage and early-stage trials. — Pipeline expansion into oral medications suggests a path toward sustained long-term revenue growth.
+0.30Which stocks this story touches
Described as a better buy than SpaceX due to its dominance in the weight loss drug market, strong profitability, and significant revenue growth.
Mentioned as having high risk, recent stock price retreat from peaks, and significant reported losses.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
No stock impact ranking available yet.
Seeking Alpha
3h ago
